Bloomberg the Company & Products

Bloomberg Anywhere Login

Bloomberg

Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.

Company

Financial Products

Enterprise Products

Media

Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000

Communications

Industry Products

Media Services

Follow Us


Last $27.88 USD
Change Today +0.28 / 1.01%
Volume 238.1K
PMC On Other Exchanges
Symbol
Exchange
New York
Frankfurt
As of 8:04 PM 03/27/15 All times are local (Market data is delayed by at least 15 minutes).

pharmerica corp (PMC) Snapshot

Open
$27.65
Previous Close
$27.60
Day High
$28.25
Day Low
$27.60
52 Week High
06/6/14 - $30.48
52 Week Low
12/17/14 - $19.42
Market Cap
840.7M
Average Volume 10 Days
293.3K
EPS TTM
$1.34
Shares Outstanding
30.2M
EX-Date
--
P/E TM
20.8x
Dividend
--
Dividend Yield
--
Current Stock Chart for PHARMERICA CORP (PMC)

pharmerica corp (PMC) Related Bloomberg News

View More Bloomberg News

pharmerica corp (PMC) Related Businessweek News

No Related Businessweek News Found

pharmerica corp (PMC) Details

PharMerica Corporation operates as an institutional pharmacy services company in the United States. The company offers services to healthcare facilities; pharmacy management services to hospitals; specialty infusion services to patients outside hospitals; and oncology pharmacy services. It purchases, repackages, and dispenses prescription and non-prescription pharmaceuticals in accordance with physician orders and delivers such medication to healthcare facilities for administration to individual patients and residents. The company also provides hospital pharmacy management services, including hospital pharmacy operations, regulatory and financial management services, and clinical pharmacy programs, as well as offers consultant pharmacist services and medical records services. It operates 98 institutional, 14 specialty infusion, and 5 specialty oncology pharmacies in 45 states, as well as provides pharmacy management services to 89 hospitals in the United States. The company serves institutional healthcare providers, such as skilled nursing facilities, nursing centers, assisted living facilities, hospitals, individuals receiving in-home care, and other long-term alternative care settings. PharMerica Corporation was founded in 2006 and is headquartered in Louisville, Kentucky.

4,800 Employees
Last Reported Date: 03/2/15
Founded in 2006

pharmerica corp (PMC) Top Compensated Officers

Chief Executive Officer, President and Direct...
Total Annual Compensation: $837.7K
Chief Financial Officer, Executive Vice Presi...
Total Annual Compensation: $192.2K
President of Amerita, Inc
Total Annual Compensation: $290.0K
Chief Compliance Officer, Senior Vice Preside...
Total Annual Compensation: $320.1K
Senior Vice President of Purchasing & Trade R...
Total Annual Compensation: $294.2K
Compensation as of Fiscal Year 2013.

pharmerica corp (PMC) Key Developments

PharMerica Signs Wholesale Drug Distribution Agreement with Cardinal Health, Effective April 1, 2015

PharMerica Corporation has signed a new wholesale drug distribution agreement with Cardinal Health, Inc. The new agreement will take effect on April 1, 2015 and extend through June 2018. As part of the agreement, Cardinal Health will assume responsibility for the sourcing and distribution of branded and generic pharmaceuticals for PharMerica.

PharMerica Corporation Announces Wholesale Drug Distribution Agreement with Cardinal Health, Inc

PharMerica Corporation announced that it has entered into a new wholesale drug distribution agreement with Cardinal Health, Inc. The new agreement will take effect on April 1, 2015 and extend through June 2018. As part of the agreement, Cardinal Health will assume responsibility for the sourcing and distribution of branded and generic pharmaceuticals for PharMerica.

Pharmerica Corporation Reports Consolidated Unaudited Earnings Results for the Fourth Quarter and Full Year Ended December 31, 2014; Provides Earnings Guidance for the First Quarter and Full Year of Fiscal 2015

PharMerica Corporation reported consolidated unaudited earnings results for the fourth quarter and full year ended December 31, 2014. For the quarter, the company reported revenues of $523.5 million compared with $450.5 million a year ago. Operating income was $12.7 million compared to $13.9 million a year ago. Income before income taxes was $9.7 million compared to $11.4 million a year ago. Net income was $3.2 million compared to $4.4 million a year ago. Diluted earnings per share were $0.10 compared to $0.15 a year ago. Net cash provided by operating activities was $50.8 million compared to $3.7 million a year ago. Purchase of equipment and leasehold improvements was $6.6 million against $6.4 million a year ago. Adjusted EBITDA was $37.3 million compared to $30.6 million a year ago. Adjusted diluted earnings per share were $0.45 compared to $0.44 a year ago. The strong revenue increase was primarily attributable to acquisitions completed in the third and fourth quarters of 2014. The quarterly sequential improvement in cash provided by operating activities was driven by an improvement in net working capital. For the year, the company reported revenues of $1,894.5 million compared to $1,757.9 million a year ago. Operating income was $30.4 million compared to $55.8 million a year ago. Income before income taxes was $16.2 million compared to $45.2 million a year ago. Net income was $6.8 million compared to $18.9 million a year ago. Diluted earnings per share were $0.22 compared to $0.63 a year ago. Net cash provided by operating activities was $48.4 million compared to $155.7 million a year ago. Purchase of equipment and leasehold improvements was $25.6 million against $27.3 million a year ago. Adjusted EBITDA was $130.6 million compared to $132.8 million a year ago. Adjusted diluted earnings per share were $1.67 compared to $1.83 a year ago. The company provided earnings guidance for the full year of fiscal 2015. For the year, the company expects revenue in the range of $1.950 billion to $2.050 billion, adjusted diluted earnings per share in the range of $1.55 to $1.65 and adjusted EBITDA in the range of $137 million to $142 million. The tax rate incorporated into 2015 guidance is 37%. For the first quarter of 2015, the company expects the adjusted diluted earnings per share range of 2015 is $0.42 to $0.45 per share.

 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
PMC:US $27.88 USD +0.28

PMC Competitors

Market data is delayed at least 15 minutes.

Company Last Change
Omnicare Inc $76.80 USD +0.93
SunLink Health Systems Inc $1.68 USD +0.0699
View Industry Companies
 

Industry Analysis

PMC

Industry Average

Valuation PMC Industry Range
Price/Earnings -- Not Meaningful
Price/Sales -- Not Meaningful
Price/Book -- Not Meaningful
Price/Cash Flow -- Not Meaningful
TEV/Sales -- Not Meaningful
 | 

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact PHARMERICA CORP, please visit www.pharmerica.com. Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.